The increase in sTIL and the changes in the expression of immune-related proteins did not correlate with Ki67 suppression at two weeks, a biomarker of response to ET, suggesting that these changes were not dependent on tumor response to treatment (Supplementary Fig. S2H–S2I). This evidence concerns the gene MKI67 and neoplasm.